Business description: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company principally engaged in research, development, production and sales of patented innovative traditional Chinese medicine. The Company operates three business sectors. The Proprietary Chinese Medicine sector is mainly engaged in multi-channel research and development of compound Chinese medicines, component Chinese medicines and single Chinese medicines. The Chemopharmaceutical sector mainly establishes chemopharmaceutical research and development platform, international standard production platform and network of overseas sales partners. The Health Industry sector has developed and launched a series of health products, including products of benefiting heart and brain, anti-aging and immunity, anti-fatigue and anti-joint, sleep and mood and Lianhua respiratory health. The Company also provides dietary supplements, healthy food and drink, disinfection products and personal protective equipment.

Number of employees: 11,708

Sales by Activity: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Fiscal Period: December20202021202220232024

Pharmaceutical Manufacturing

8.78B 10.12B 12.53B 10.32B 6.51B
See all business segments

Geographical breakdown of sales: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Fiscal Period: December20202021202220232024

China

8.48B 9.76B 12.07B 10.08B 6.22B

Foreign

304M 357M 463M 239M 295M
See all geographic segments

Executive Committee: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Manager TitleAgeSince
Chief Executive Officer 50 2013-03-31
Director of Finance/CFO 52 2018-04-23
Corporate Officer/Principal 55 2020-01-15
Corporate Secretary 45 2010-08-30
Investor Relations Contact - -
See SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. governance

Composition of the Board of Directors: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Director TitleAgeSince
Chairman 76 2012-08-30
Director/Board Member 50 2010-08-30
Director/Board Member 52 2018-05-16
Chairman 55 2014-08-18
Director/Board Member 46 2009-02-28
Director/Board Member 45 2016-12-11
Director/Board Member 52 2014-08-17
Director/Board Member 52 2016-12-11
Director/Board Member 55 2015-03-15
Director/Board Member 57 2020-01-15
Composition of the Board of Directors

Shareholders: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

NameEquities%Valuation
China Southern Asset Management Co., Ltd.
0.8658 %
11,913,199 0.8658 % 23 M ¥
China Asset Management Co., Ltd.
0.1817 %
2,500,731 0.1817 % 5 M ¥
Guotai Asset Management Co., Ltd.
0.1014 %
1,395,302 0.1014 % 3 M ¥
Penghua Fund Management Co., Ltd.
0.1008 %
1,387,420 0.1008 % 3 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.0959 %
1,319,080 0.0959 % 3 M ¥
List of SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. shareholders

Company details: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

No. 238 Tianshan Avenue High-tech Industrial Dev Zone

050035, Shijiazhuang

+86 311 8590 1712

http://www.yiling.cn
address Shijiazhuang Yiling Pharmaceutical Co., Ltd.(002603)

Alternative Medicine

Change 5d. change 1-year change 3-years change Capi.($)
+0.07%-0.53%-4.48%-42.94% 3.48B
+0.60%-1.19%-9.23%+34.66% 4.53B
-0.08%+0.69%-17.57%+5.34% 3.37B
-0.25%-0.50%+22.87%+52.26% 3.3B
+0.73%+2.28%+3.01%+38.94% 3.12B
+0.42%+1.56%+8.83%-13.21% 2.49B
+1.67%-0.68%+25.58%+92.35% 1.82B
-0.26%-2.64%-3.94%+92.44% 1.8B
-0.25%+0.25%+25.95%-43.63% 1.67B
+0.09%-1.23%+16.18%-12.98% 1.66B
Average +0.27%+0.39%+6.72%+20.32% 2.72B
Weighted average by Cap. +0.28%+0.47%+3.67%+19.35%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
14.92CNY
Average target price
15.38CNY
Spread / Average Target
+3.08%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002603 Stock
  4. Company Shijiazhuang Yiling Pharmaceutical Co., Ltd.